Artelo Biosciences (ARTL) Common Equity (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly Common Equity of -$1.3 million for Q4 2025, down 144.52% year-over-year from $2.9 million in Q4 2024, and down 100.95% quarter-over-quarter from -$633000.0 in Q3 2025.
Artelo Biosciences (ARTL) Common Equity (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Common Equity for 12 consecutive years, with -$1.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Common Equity fell 144.52% year-over-year to -$1.3 million; the TTM figure through Dec 2025 stood at -$1.3 million (down 144.52% YoY), while the FY2025 annual figure was -$1.3 million, down 144.52% from the prior year.
- Common Equity fell to -$1.3 million in Q4 2025 per ARTL's latest filing, from -$633000.0 in the prior quarter.
- Across five years, Common Equity topped out at $28.3 million in Q4 2021 and bottomed at -$1.4 million in Q2 2025.
- Historically, Common Equity has averaged $12.0 million across 5 years, with a median of $12.0 million in 2021.
- Annual changes were most pronounced in 2021 — Common Equity jumped 269.47% — and 2025, when it sank 144.52%.
- Artelo Biosciences' Common Equity stood at $28.3 million in 2021, then slumped by 31.4% to $19.4 million in 2022, then plunged by 39.43% to $11.8 million in 2023, then plunged by 75.69% to $2.9 million in 2024, then slumped by 144.52% to -$1.3 million in 2025.
- Business Quant data shows ARTL's Common Equity at -$1.3 million in Q4 2025, -$633000.0 in Q3 2025, and -$1.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.35 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 757.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.79 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 22.38 Bn |
| 10 | Artelo Biosciences | 111,698.23 | -488,301.77 | - | -1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.27 Mn |
| Sep 30, 2025 | -633,000.00 |
| Jun 30, 2025 | -1.41 Mn |
| Mar 31, 2025 | 652,000.00 |
| Dec 31, 2024 | 2.86 Mn |
| Sep 30, 2024 | 6.36 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 9.54 Mn |
| Dec 31, 2023 | 11.75 Mn |
| Sep 30, 2023 | 14.58 Mn |
| Jun 30, 2023 | 16.27 Mn |
| Mar 31, 2023 | 17.64 Mn |
| Dec 31, 2022 | 19.40 Mn |
| Sep 30, 2022 | 21.90 Mn |
| Jun 30, 2022 | 23.84 Mn |
| Mar 31, 2022 | 25.78 Mn |
| Nov 30, 2021 | 28.29 Mn |
| Aug 31, 2021 | 12.04 Mn |
| May 31, 2021 | 11.92 Mn |
| Feb 28, 2021 | 12.86 Mn |